logo
Book a meeting
Opus Genetics

Opus Genetics

Biotechnology, 8 Davis Dr Ste 220, Raleigh, North Carolina, 27709, United States, 11-50 Employees

opusgtx.com

  • twitter
  • LinkedIn

phone no Phone Number: 19*********

Who is OPUS GENETICS

Opus Genetics is a groundbreaking clinical-stage gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindnesss venture arm,...

Read More

lock icon Get Full Access
map
  • 8 Davis Dr Ste 220, Raleigh, North Carolina, 27709, United States Headquarters: 8 Davis Dr Ste 220, Raleigh, North Carolina, 27709, United States
  • 2021 Date Founded: 2021
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from OPUS GENETICS

Opus Genetics Org Chart and Mapping

Employees
Lilia Koza

Lilia Koza

Associate Scientist

Ash Jayagopal

Ash Jayagopal

Chief Scientific Officer

Mayur Choudhary

Mayur Choudhary

Senior Scientist

See Full Org Chart arrow
email-formate-icon
View Email Formats for Opus Genetics
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Opus Genetics

Answer: Opus Genetics's headquarters are located at 8 Davis Dr Ste 220, Raleigh, North Carolina, 27709, United States

Answer: Opus Genetics's phone number is 19*********

Answer: Opus Genetics's official website is https://opusgtx.com

Answer: Opus Genetics's revenue is $1 Million to $5 Million

Answer: Opus Genetics's SIC: 2836

Answer: Opus Genetics's NAICS: 541714

Answer: Opus Genetics has 11-50 employees

Answer: Opus Genetics is in Biotechnology

Answer: Opus Genetics contact info: Phone number: 19********* Website: https://opusgtx.com

Answer: Opus Genetics is a groundbreaking clinical-stage gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindnesss venture arm, the RD Fund, Opus combines unparalleled insight and commitment to patient need with wholly owned programs in numerous inherited retinal diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access